[144] IonQ, Inc. SEC Filing

Rhea-AI Filing Summary

Accenture plc (ACN) – Form 4 insider transaction

General Counsel and Corporate Secretary Joel Unruch reported the purchase of 90 Class A ordinary shares on 05 July 2025 at an average price of $303.795 per share. The acquisition was made through the company’s Voluntary Equity Investment Program, a payroll-deduction plan that allows executives to buy stock directly from Accenture. Following the transaction, Unruch’s direct holdings increased to 17,541 shares.

No derivative securities were involved and no dispositions were reported. The filing reflects an incremental ownership increase of roughly 0.5% to Unruch’s personal stake and is immaterial relative to Accenture’s total shares outstanding. Because the shares were purchased under a pre-arranged company program rather than on the open market, the signal is less indicative of discretionary conviction, but it nevertheless aligns executive interests with shareholders.

Positive

• Insider purchase: Officer acquired 90 shares, which marginally increases alignment with shareholders.

Negative

• Immaterial size: Purchase value (~$27k) is insignificant relative to Accenture’s market capitalization and unlikely to affect valuation.
• Programmatic acquisition: Shares were bought under a preset company plan, reducing the discretionary signal typically associated with insider buying.

Insights

Securities Analyst

TL;DR: Routine 90-share insider buy through company plan; modest, largely neutral impact.

The Form 4 shows Accenture’s General Counsel adding 90 shares via the Voluntary Equity Investment Program at ~$304, raising his direct stake to 17,541 shares. While any insider purchase is directionally positive, the dollar value (~$27k) is negligible against Accenture’s $200 bn+ market cap. Importantly, purchases executed through standing company plans carry less signaling power than open-market buys. Overall, this is a routine administrative filing with limited market relevance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	45000	1997550.00	247783086	07/07/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/07/2025	Exercise of Stock Options	Issuer			45000	07/07/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for RIMA IBRAHIM 4505 Campus Drive College Park MD 20740	Common	06/13/2025	65000	2506758.50
RIMA ALAMEDDINE 4505 Campus Drive College Park MD 20740	Common	06/11/2025	19976	830909.71

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider activity did ACN report on 07/05/2025?

General Counsel Joel Unruch purchased 90 Class A shares at $303.795 each.

How many Accenture shares does Joel Unruch own after the transaction?

His direct holdings increased to 17,541 shares.

Was the purchase an open-market buy?

No. It was made through Accenture’s Voluntary Equity Investment Program.

Does the filing involve any derivative securities?

No derivative securities were acquired or disposed of in this Form 4.

Is the insider purchase considered material for investors?

Given the small size (~$27k), it is viewed as immaterial to Accenture’s valuation.